News for Sanara MedTech Inc. (SMTI)

Sanara MedTech's Surgical unit grew 26% with 92% margins, driving EBITDA gains despite THP losses, debt, and interest risks. Read why SMTI stock is a buy.

In a recent analyst update, HC Wainwright & Co. has maintained their

Net Revenue: $23.4 million, 26% growth year over year.Soft Tissue Repair Products Revenue: $20.5 million, 28% growth year over year.Bone Fusion Products Revenu

May 14, 2025 / 12:00PM GMTOperator Welcome to the Sanara MedTech first quarter of 2025 earnings conference call. Please note that this conference call is being

Sanara MedTech's Q1 2025 earnings show 26% revenue growth, stronger distributor networks, & new product launches.

Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ETCompany ParticipantsRon Nixon - Executive Chairman, Chief...

Key Highlights: Sanara MedTech (SMTI) exceeds EPS expectations in Q1 despite a slight revenue shortfall. Analysts predict substantial upside with a targe

Sanara MedTech (SMTI) delivered earnings and revenue surprises of -32.26% and 5.32%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Sanara MedTech Inc. (SMTI) reported a significant revenue increase in the first quarter of 2025, generating $23.4 million compared to $18.5 million in the same

Revenue: $23.4 million, slightly below the estimated $23.48 million, but up 26% year-over-year.Net Loss: Increased to $3.5 million from $1.8 million in the sam

**media[625349]**

FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (”œSanara,” or the ”œCompany”) ( SMTI), a medical technology company focused on d

FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (”œSanara,” the ”œCompany,” ”œwe,” ”œour” or ”œus”) ( SMTI), a medical t

**media[592026]**

Sanara MedTech (SMTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Discover how Sanara MedTech drives 33% revenue growth with innovation in wound care and surgical products.

Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2024 Earnings Conference Call March 25, 2025 8:00 AM ETCompany ParticipantsRon Nixon - Executive Chairman and Chief...

Revenue: $26.3 million for Q4 2024, surpassing the estimated $25.80 million and marking a 49% increase year-over-year.Net Loss: $1.7 million for Q4 2024, compa

Sanara MedTech Inc (SMTI) is set to release its Q4 2024 earnings on Mar 25, 2025. The consensus estimate for Q4 2024 revenue is $25.80 million, and the earnings